The Board of Directors of Celltrion, Inc. has authorized a buyback plan on March 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,94,600 KRW | +0.10% | +2.96% | -3.42% |
24/04 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
17/04 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.42% | 29.71B | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B | |
+18.74% | 11.81B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion, Inc. authorizes a Buyback Plan.